KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Receivables (2016 - 2026)

Amgen has reported Change in Receivables over the past 18 years, most recently at -$413.0 million for Q1 2026.

  • For Q1 2026, Change in Receivables fell 131.57% year-over-year to -$413.0 million; the TTM value through Mar 2026 reached $955.0 million, down 29.42%, while the annual FY2025 figure was $2.7 billion, 706.8% up from the prior year.
  • Change in Receivables for Q1 2026 was -$413.0 million at Amgen, down from $1.1 billion in the prior quarter.
  • Over five years, Change in Receivables peaked at $1.3 billion in Q1 2025 and troughed at -$486.0 million in Q1 2024.
  • A 5-year average of $210.8 million and a median of $180.0 million in 2022 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: skyrocketed 451.79% in 2022 and later plummeted 437.5% in 2024.
  • Year by year, Change in Receivables stood at $180.0 million in 2022, then surged by 140.56% to $433.0 million in 2023, then plummeted by 209.24% to -$473.0 million in 2024, then skyrocketed by 327.27% to $1.1 billion in 2025, then tumbled by 138.42% to -$413.0 million in 2026.
  • Business Quant data shows Change in Receivables for AMGN at -$413.0 million in Q1 2026, $1.1 billion in Q4 2025, and -$222.0 million in Q3 2025.